Alisha Alaimo

Alisha A. Alaimo is President, Head of North America, responsible for the commercial operations in the United States and Canada and a Board Member of the Biogen Foundation. Ms. Alaimo is an accomplished global executive with extensive experience in leading strategy, sales, marketing, market access, key account management, advocacy and medical functions. Prior to joining Biogen in 2017 to lead the company’s U.S. business, Ms. Alaimo spent 17 years at Novartis Pharmaceuticals in global product development, global brand strategy and regional leadership roles in Switzerland, the United Kingdom and the U.S. With increasing roles of responsibility, Ms. Alaimo focused on driving growth and people development in the company’s high-profile, priority franchises including cardiovascular, metabolic, autoimmunity, rare disease, transplant and neuroscience. Ms. Alaimo started her career in commercial roles at Johnson & Johnson.

Ms. Alaimo holds a Bachelor of Science from Emory University and has completed courses at Harvard University and Tufts University in clinical pharmacology, drug development and regulation and business finance.